The vote was unanimous among its 16 members, and the committee agreed that the issue doesn’t need to be studied any further. On Tuesday, the committee voted no on the specific question: “Do the current scientific data that were presented support that the monograph dosage of orally administered phenylephrine is effective as a nasal decongestant.” These products generated nearly $1.8 billion in sales last year alone, according to data from the FDA that was presented to the Nonprescription Drugs Advisory Committee on Monday during the committee’s two-day meeting. But many doctors have questioned phenylephrine’s effectiveness for years. The ingredient is considered safe to use that was not up for debate. Tim Boyle/Getty Images/FileįDA committee to consider whether ingredient in many popular decongestants actually works
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |